BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8247116)

  • 1. Trial deaths prompt tighter rules.
    Macilwain C
    Nature; 1993 Nov; 366(6453):294. PubMed ID: 8247116
    [No Abstract]   [Full Text] [Related]  

  • 2. Concern grows over reaction to deaths in clinical trials.
    Macilwain C
    Nature; 1994 May; 369(6478):268. PubMed ID: 8183354
    [No Abstract]   [Full Text] [Related]  

  • 3. NIH, FDA seek lessons from hepatitis B drug trial deaths.
    Macilwain C
    Nature; 1993 Jul; 364(6435):275. PubMed ID: 8332178
    [No Abstract]   [Full Text] [Related]  

  • 4. IOM panel exonerates researchers in FIAU deaths.
    Marwick C
    JAMA; 1995 Apr; 273(15):1165. PubMed ID: 7707610
    [No Abstract]   [Full Text] [Related]  

  • 5. Panel clears NIH in patient deaths.
    Stone R
    Science; 1995 Mar; 267(5205):1759. PubMed ID: 7892593
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis study. Drug trial deaths deemed unavoidable.
    Marshall E
    Science; 1994 Jun; 264(5165):1530. PubMed ID: 8202706
    [No Abstract]   [Full Text] [Related]  

  • 7. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
    Lovell MC
    Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
    [No Abstract]   [Full Text] [Related]  

  • 8. US health agencies at odds over trial deaths.
    Macilwain C
    Nature; 1994 Jun; 369(6480):433. PubMed ID: 8202125
    [No Abstract]   [Full Text] [Related]  

  • 9. NIH panel report of 'no flaws' in FIAU trial at variance with FDA report, new probe planned.
    Marwick C
    JAMA; 1994 Jul; 272(1):9-11. PubMed ID: 8007087
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial toxicity--new adverse drug effects.
    Swartz MN
    N Engl J Med; 1995 Oct; 333(17):1146-8. PubMed ID: 7565955
    [No Abstract]   [Full Text] [Related]  

  • 11. The context of consent.
    Horton R
    Lancet; 1994 Jul; 344(8917):211-2. PubMed ID: 7913152
    [No Abstract]   [Full Text] [Related]  

  • 12. Deaths bring clinical trials under scrutiny in Japan.
    Swinbanks D
    Nature; 1994 Jun; 369(6483):697. PubMed ID: 8008052
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA penalizes trial misconduct.
    Shaffer C
    Nat Biotechnol; 2009 Oct; 27(10):872. PubMed ID: 19816424
    [No Abstract]   [Full Text] [Related]  

  • 14. Trials on trial.
    Nature; 2008 May; 453(7194):427-8. PubMed ID: 18497763
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
    James JS
    AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 17. Safeguarding clinical trials.
    Nat Med; 2007 Feb; 13(2):107. PubMed ID: 17290249
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe toxicity of fialuridine (FIAU).
    Josephson L
    N Engl J Med; 1996 Apr; 334(17):1135-6; author reply 1137-8. PubMed ID: 8598880
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs tests on trial.
    Nature; 2006 Apr; 440(7087):970. PubMed ID: 16625159
    [No Abstract]   [Full Text] [Related]  

  • 20. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.